3070 N0 domain in phage tail proteins and secretins-like
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Homogeneous metal compounds | 10 | 10.2 | 0.98× | q = 1.00 | |
| Nucleosides, nucleotides, and analogues | 0 | 5.7 | 0 | q = 4.9e-3 | |
| Phenylpropanoids and polyketides | 2 | 0.4 | 4.64× | not tested | |
| Organic acids and derivatives | 6 | 3.2 | 1.87× | not tested | |
| Lipids and lipid-like molecules | 3 | 2.3 | 1.30× | not tested | |
| Organoheterocyclic compounds | 2 | 3.2 | 0.63× | not tested | |
| Homogeneous non-metal compounds | 2 | 4.5 | 0.45× | not tested | |
| Organic oxygen compounds | 1 | 4.1 | 0.24× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03574 | FCI | Ferricrocin-iron | 4 |
| DB00115 | CNC | Cyanocobalamin | 3 |
| DB08217 | MTN | S-[(1-Hydroxy-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate | 2 |
| DB09459 | TLA | L-tartaric acid | 2 |
| DB18267 | HEM | Ferroheme | 2 |
| DB01747 | HWS | Coprogen | 1 |
| DB02626 | PFC | Phenylferricrocin-iron | 1 |
| DB02724 | ALB | Delta-2-Albomycin A1 | 1 |
| DB04220 | RIF | CGP 4832 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| CUmetal | COPPER (II) ION | 12 |
| AGmetal | SILVER ION | 10 |
| PVE | (1S)-1-CARBOXY-5-[(3-CARBOXYPROPANOYL)AMINO]-8,9-DIHYDROXY-1,2,3,4-TETRAHYDROPYRIMIDO[1,2-A]QUINOLIN-11-IUM | 10 |
| FEmetal | FE (III) ION | 9 |
| Kmetal | POTASSIUM ION | 7 |
| CL | CHLORIDE ION | 6 |
| NAmetal | SODIUM ION | 6 |
| FCI | FERRICROCIN-IRON | 4 |
| ZNmetal | ZINC ION | 4 |
| 0UE | Ferrioxamine B | 3 |
| 188 | PYOCHELIN FE(III) | 3 |
| CNC | CYANOCOBALAMIN | 3 |
| FV8 | (4~{S},5~{R})-2-[2,3-bis(oxidanyl)phenyl]-~{N}-[2-(1~{H}-imidazol-4-yl)ethyl]-5-methyl-~{N}-oxidanyl-4,5-dihydro-1,3-oxazole-4-carboxamide | 3 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 3 |
| A1H49 | 2-(2-hydroxyphenyl)-1,3-thiazole-4-carboxylic acid | 2 |
| A1IG8 | Pyochelin Fe(III) isomer | 2 |
| A1IJR | ~{N}-[(~{E},5~{S})-6-[2-[2-(2-azanylethoxy)ethoxy]ethylamino]-5-[[2-(2-hydroxyphenyl)-1,3-thiazol-4-yl]carbonylamino]-6-oxidanylidene-hex-2-enyl]-2-(2-hydroxyphenyl)-1,3-thiazole-4-carboxamide | 2 |
| CAmetal | CALCIUM ION | 2 |
| CU1metal | COPPER (I) ION | 2 |
| EFE | ENANTIO-PYOCHELIN FE(III) | 2 |